Vertex Pharmaceuticals Investment Income decreased by 2.6% to $114.80M in Q1 2026 compared to the prior quarter.
mu_investment_income_net| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $117.90M | $114.80M |
| QoQ Change | — | -2.6% |
| YoY Change | — | -2.6% |
| Segment | Q1 '26 |
|---|---|
| Pharmaceuticals | $114.80M |
| Total | $114.80M |